Procter & Gamble vs. Colgate: Which Dividend Stock Rules Them All

• Procter & Gamble (PG) reported level integrated income successful Q2 FY2026 with 1% pricing offset by 1% measurement decline, portion facing $400M successful yearly tariff costs and 6.53% operating income diminution contempt 1.5% gross growth.

• Colgate-Palmolive (CL) posted stronger Q4 2025 with 2.2% integrated income maturation and $5.23B gross beating estimates by 2.04%, though a $919M Filorga goodwill impairment resulted successful antagonistic $0.05 GAAP EPS.

• Procter & Gamble pursues large-scale restructuring with 7,000 overhead cuts and 26.16% capex maturation to offset tariff resistance and stabilize margins, portion Colgate targets faster execution done AI analytics and its 2030 strategy, creating divergent risk-reward profiles for semipermanent dividend investors.

• The expert who called NVIDIA successful 2010 conscionable named his apical 10 AI stocks. Get them present FREE.

Procter & Gamble's Q2 FY2026 showed a concern holding crushed alternatively than accelerating. Organic income came successful flat, with 1% pricing offset by a 1% portion measurement decline. Beauty led with 5% integrated growth, and Health Care matched that pace. Baby, Feminine & Family Care weakened, wherever integrated income fell 4%, with Family Care down treble digits.

READ: The expert who called NVIDIA successful 2010 just named his apical 10 AI stocks

Colgate's Q4 2025 told a livelier top-line story. Revenue roseate 5.8% year-over-year to $5.23 billion, beating estimates by 2.04%. Organic income grew 2.2%, with 3.1% overseas speech tailwind amplifying the headline. Hill's Pet Nutrition contributed $1.20 billion, up 4.9%, and Africa/Eurasia surged 10.3% organically.

North America slipped 1.8% organically. The 4th carried a achy footnote: a $919 cardinal goodwill impairment connected the Filorga tegument wellness business, driven by anemic China performance, pushing GAAP EPS to -$0.05.

Procter & Gamble is restructuring astatine scale. The June 2025 portfolio and productivity program targets up to 7,000 non-manufacturing overhead cuts by extremity of FY2027, and superior expenditures jumped 26.16% year-over-year successful Q2. The institution absorbs astir $400 cardinal successful after-tax tariff costs this fiscal year. Operating income fell 6.53% year-over-year contempt gross rising 1.5%, arsenic restructuring costs and tariff resistance compress margins.